[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624500":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":32,"responsibleParty":60,"collaborators":10,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":10,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":10,"studyType":75,"phases":10,"briefSummary":76,"conditions":77,"keywords":81,"overallStatus":56,"whyStopped":10,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"University of Florida","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Distal Shoe Therapy Cohort",null,"This cohort includes pediatric patients, aged 3 to 9 years (ASA I or II), for whom distal shoe therapy has been clinically indicated as the standard of care (SOC). Participants undergo routine appliance fabrication and placement as part of their standard clinical care. The cohort will be prospectively monitored during SOC follow-up visits (at 1-week and 3-month intervals) to evaluate soft tissue health, gingival inflammation, and the successful eruption of the permanent first molar. Individual participation typically ranges from 12 to 24 months.",[13],"Other: Standard Clinical Practice Regimen",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Standard Clinical Practice Regimen","his study involves the prospective observational monitoring of clinical outcomes during standard distal shoe therapy. Research activities consist of systematic documentation of clinical data, including radiographic assessment of the intra-alveolar blade depth measured from the mesial margin of the permanent first molar, standardized gingival health scores, and caregiver-reported compliance. No experimental modifications to the clinical device or surgical procedures are performed, ensuring the study reflects routine clinical practice.",[9],[20],{"name":21,"affiliation":5,"role":22},"Mi Sook Lee, DMD, MSD, PhD","PRINCIPAL_INVESTIGATOR",[24,28],{"name":21,"role":25,"phone":26,"phoneExt":10,"email":27},"CONTACT","352-273-7643","misooklee@ufl.edu",{"name":29,"role":25,"phone":30,"phoneExt":10,"email":31},"Marcio Guelmann, DDS","352-273-7635","mguelmann@dental.ufl.edu",[33,55],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Department of Pediatric Dentistry, Universit of Florida, College of Dentistry","NOT_YET_RECRUITING","Gainesville","Florida","32610","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-82.32483,29.65163,{"lat":45,"lon":44},[48,49,50,51,53],{"name":21,"role":25,"phone":26,"phoneExt":10,"email":27},{"name":29,"role":25,"phone":30,"phoneExt":10,"email":31},{"name":21,"role":22,"phone":10,"phoneExt":10,"email":10},{"name":29,"role":52,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"name":54,"role":52,"phone":10,"phoneExt":10,"email":10},"Tyler Chin, DMD",{"facility":5,"status":56,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":57,"geoPoint":59,"contacts":10},"RECRUITING",{"type":42,"coordinates":58},[44,45],{"lat":45,"lon":44},{"type":61,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100624500","clinical-safety-guidelines-for-managing-distal-shoe-complications-100624500",false,"NCT07410442","Clinical Safety Guidelines for Managing Distal Shoe Complications","Soft Tissue Complications and Clinical Decision-Making in Distal Shoe Therapy: A Prospective Clinical Follow-Up Study","Inclusion Criteria\n\n* Pediatric participants aged 3 to 9 years\n* American Society of Anesthesiologists (ASA) Physical Status I or II\n* Clinical indication for distal shoe therapy as the standard of care\n* Undergoing distal shoe space maintainer placement\n* Parent or caregiver able to provide consent and comply with follow-up visits\n\nExclusion Criteria\n\n* Presence of systemic medical conditions that may affect bone metabolism or wound healing\n* Patients unable or unwilling to comply with the planned follow-up schedule (up to 24 months)\n* Patients with contraindications to distal shoe therapy based on clinical judgment","ALL","3 Years","9 Years",{"count":73,"type":74},50,"ESTIMATED","OBSERVATIONAL","Distal shoe space maintainers are the standard of care for guiding the eruption of permanent first molars following the premature loss of the primary second molars. Although this therapy represents established clinical practice, prospective evidence regarding soft tissue complications and predictors of treatment outcomes remains limited. This observational study will prospectively collect clinical outcome data during routine treatment visits. The aims of the study are to characterize patterns of complications, evaluate outcomes related to patient adherence, and identify predictors of treatment success. Ultimately, this study seeks to support the development of standardized strategies for clinical monitoring and complication management.",[78,79,80],"Premature Loss of Primary Molars","Space Maintainer","Soft Tissue Inflammation",[82,83,84],"primary second molar","distal shoe","soft tissue complications","2026-05-07",{"date":87,"type":88},"2026-05-12","ACTUAL",{"date":90,"type":74},"2026-05",{"date":92,"type":74},"2029-02",{"name":5,"class":6},2]